ADVA
6.10.2020 09:02:14 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced the general availability of its Ensemble Activator , the market’s first carrier-grade network operating system (NOS) designed for disaggregated cell site gateways (DCSGs). Already successful in trials with multiple global mobile network operators (MNOs) including Telefónica and Vodafone, Ensemble Activator disaggregates hardware from software, giving customers new levels of agility and freedom. Developed as part of the Telecom Infra Project (TIP), the feature-rich software enables MNOs to move away from closed proprietary systems and build open, vendor-neutral transport infrastructure with best-of-breed components. Now ready for commercial deployment in mobile networks, it offers MNOs a clear route to cost-effective mass rollout of 5G services.
“Today’s announcement marks the start of a new age of disaggregated mobile networks. By deploying our Ensemble Activator, MNOs will be able to leverage the full benefits of separated software and hardware and inject unprecedented speed, efficiency and flexibility into their transport infrastructure,” said Eli Angel, VP, product line management, Ethernet access, ADVA. “Built on our team’s vast experience equipping the largest public networks with the most advanced connectivity solutions, Ensemble Activator has now proven itself in a wide range of real-life scenarios. These include 5G field trials where Ensemble Activator combined with third-party white box hardware to create an open and cohesive DCSG solution . By turning cost-effective bare-metal switches into powerful packet network devices, it will equip MNOs to build tomorrow’s mobile infrastructure.”
Engineered through the TIP Disaggregated Cell Site Gateway group, ADVA’s Ensemble Activator is optimized for the operation of large, geographically dispersed networks. Proven in multiple tests with third-party hardware from suppliers such as Alpha Networks, Delta and Edgecore, it integrates seamlessly into existing management and control systems. With its carrier-class capabilities, Ensemble Activator offers a way to grow mobile networks that combines the agility of software-based feature development with the performance and cost-efficiency of bare-metal switches. Its comprehensive set of CE 2.0- and MEF 3.0-compliant interfaces is complemented with proven IP and MPLS protocols. What’s more, with its open control interfaces and telemetry streaming, Ensemble Activator is a significant step towards automated and eventually autonomous operations.
“Supporting the disaggregation of hardware and software while meeting the performance needs of the most demanding mobile networks is critical in transitioning today’s technology to open, highly scalable mobile transport architectures and enabling the mass rollout of 5G services. We are very excited about ADVA’s Ensemble Activator, as it offers something new to the market and enables a strong ecosystem for DCSG technology,” commented Luis MartinGarcia, manager, network technologies, Facebook and co-chair, DCSG group, TIP. “TIP is all about unleashing the power of collaboration and open innovation, and ADVA’s work demonstrates how quickly we build together in TIP to bring a powerful new technology to maturity.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005045/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kiabi Selects Navan to Centralise Global Travel Program11.5.2026 09:00:00 CEST | Press release
Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced it has been selected by Kiabi, the French multinational fashion retailer, to consolidate its global travel with one unified platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511547434/en/ Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform To support its workforce of nearly 10,000 “Kiabers,” the retailer required a solution capable of providing an easy-to-use travel platform. Navan was selected due to its intuitive AI-powered interface and ability to integrate with Kiabi’s travel policies directly in-app. “Managing travel was becoming an administrative burden that slowed our teams down,” said Denise Maurice, Indirect Procurement Director at Kiabi. “We wanted to give our ‘Kiabers’ the
Owl Labs partners with Westcoast to expand access to seamless hybrid meeting experiences in the UK and Ireland11.5.2026 09:00:00 CEST | Press release
Partnership aims to reduce the ‘meeting tax’ by expanding access to Owl Labs products through Westcoast’s extensive distribution network Owl Labs, a global leader in AI-powered, 360-degree video conferencing solutions, today announced a new UK and Ireland distribution partnership with Westcoast Limited, one of the country’s largest and most trusted IT distributors. The agreement will see Westcoast distribute the full range of Owl Labs’ award-winning Meeting Owl and Owl Bar products across the UK and Ireland, providing greater choice, availability, and dedicated support for resellers and end customers navigating the demands of hybrid work. The partnership aims to address the technical setup challenges that plague meetings across the UK. Owl Labs’ recent State of Hybrid Work report found that nearly 8 in 10 workers (79%) lose time in meetings due to technical difficulties such as connecting to a meeting or setting up a camera. By making Owl Labs’ solutions simpler to source, deploy and s
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay11.5.2026 09:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA). “With Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma now CE‑marked on our LUMIPULSE G platform, we are advancing a new era of neurology diagnostics—one where blood‑based biomarkers enable earlier, broader, and more accessible insights into Alzheimer’s disease and neurodegeneration.” said Christiaan De Wilde, CEO at Fujirebio Europe N.V. “By delivering fully automated and scalable solutions, we are helping clinicians move decisively toward more timely and informed decision‑making. This milestone underscores our long‑term vision to reimagine the diagnostic
Mevion Introduces the First Proton Therapy System Designed for a LINAC Vault at ESTRO 202611.5.2026 08:00:00 CEST | Press release
The MEVION S250-FIT™ creates a new pathway for European cancer centers to integrate proton therapy into existing radiotherapy programs Proton therapy is entering the LINAC vault. At ESTRO 2026, Mevion Medical Systems will introduce the MEVION S250-FIT Proton Therapy System to the European radiation oncology community, the first proton therapy system designed for installation in a standard radiation therapy vault. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507172087/en/ The MEVION S250-FIT™ Proton Therapy System Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatment environments, aligning advanced proton capability with the infrastructure, workflows, and capital planning of modern radiation oncology. Stanford Medicine: First S250-FIT Installation On April 7, 2026, Stanford Medicine unveiled
Vedanta FY26 Profit Soars by 22% to $2.8 bn; Enters Demerger Phase11.5.2026 02:30:00 CEST | Press release
India-based Vedanta Limited (BSE: 500295 & NSE: VEDL), a global leader in metals, oil & gas, critical minerals, power and technology, announced its results for the fourth quarter and full year ended 31 March 2026. It has delivered its best-ever financial performance, driven by structurally strong businesses and disciplined execution. For the full year, Vedanta’s Profit stood at an all-time high of $2.8 bn, reflecting a 22% YoY increase and a profit of $1 bn in Q4 FY26, up nearly 90% YoY. Vedanta reported its highest-ever annual revenue of about $20 bn, up 15% YoY, with Q4 revenue at $5.6 bn, an increase of nearly 30% YoY. The Company maintained strong cost leadership, contributing to record EBITDA of $6.3 bn for FY26, up by about 30% YoY, with margins expanding to around 40%. Q4 EBITDA stood at $2.0 bn, up by nearly 60% YoY, with a margin of approximately 44%. The balance sheet strengthened further, with Net Debt/EBITDA improving to 0.95x, supported by strong cash generation. Underscor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom